Objective: To determine whether vaginal breech delivery is associated with increased morbidity in term breech singletons using strict selection criteria. This study encompasses our previous studies (in 1987 and 1995) and extends our experience to 21 years.
Introduction
The published literature describing the outcomes associated with vaginal breech delivery is varied and contradictory. The reported experience at individual hospitals generally reveals no difference in outcome, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] whereas pooled estimates from many institutions or in the form of meta-analyses shows increased neonatal mortality and morbidity in the vaginal delivery group. [13] [14] [15] However, as acknowledged in the studies using pooled estimates, one must pool deliveries selected and managed in very individual ways. In addition, long-term studies have not found mode of delivery to be associated with significant differences in neurological outcomes. [16] [17] [18] In 2000, the Term Breech Trial Collaborative Group published the results of a randomized, multicenter trial comparing planned cesarean section to planned vaginal birth for term fetuses with a breech presentation. 19 The trial included many different hospitals providing for a large sample size and wide generalizability, but did not mandate consistent selection criteria. This trial was stopped early secondary to data indicating that perinatal mortality, neonatal mortality and serious neonatal morbidity in the planned vaginal birth arm were higher than in the planned cesarean arm. Based on this trial, the American College of Obstetricians and Gynecologists (ACOG) published a committee opinion stating that 'patients with persistent breech presentation at term in a singleton gestation should undergo a planned cesarean delivery.' 20 The discussion surrounding this trial and the subsequent ACOG opinion has been extensive. Although the trial was designed with great methodologic rigor to answer important questions related to breech delivery, its generalizability to all clinical settings is questionable. In addition, the high rate of perinatal deaths in the trial is concerning, but the specific details of these deaths revealed a wide range of presumed causes. In fact, as described in the accompanying commentary, most deaths were in infants or fetuses that should have been excluded, were unrelated to mode of delivery or were preventable if timely delivery had occurred. 21 Thus, the question still remains whether continuously monitored labor in appropriately selected patients can lead to safe vaginal delivery of the term breech. However, no further randomized controlled trials will likely be conducted in the United States owing to the ACOG committee opinion precluding a planned vaginal delivery arm as a viable option. Continued retrospective studies, therefore, are warranted in order to decipher whether past experience outcomes support or refute a trial of vaginal delivery.
We conducted a retrospective study to evaluate whether strict criteria to select term breeches for attempt at vaginal delivery versus cesarean section is associated with better, worse or equivalent neonatal and maternal outcomes over a 21-year experience at a university hospital. This study is unique given our consistent management of the term breech during this time period. We have previously published our outcomes for the period through 1992. 4, 7 The present study extends the analysis through 2001 in order to provide an ongoing update of our clinical experience.
Materials and methods
We designed a retrospective cohort study using the University of California, San Francisco (UCSF) perinatal database and directed chart review. The database includes comprehensive information on every delivery performed since 1976 to the present. Maternal data are collected by the physician at delivery and chart review by trained medical abstractors. Neonatal data are collected similarly. A data input software program in Access (Microsoft -Redmond, WA, USA) assists in logic checking. Medical chart review was used for verification and clarification of pertinent information.
All women with a singleton, term (37-42 weeks) gestation between 1980 and 2001were included. Exclusion criteria included known major fetal anomaly or preexisting disease, major preexisting maternal disease and intrauterine fetal demise.
The decision to use data between 1980 and 2001 was based on the adoption of strict selection criteria beginning in 1980. Candidates for external cephalic version were offered that procedure. If version was declined or attempted but failed, a trial of vaginal delivery was offered to women with the following criteria: (1) fetal weight equal to or less than 3850 g as estimated by ultrasound, (2) computerized tomography pelvimetry with at least 10 cm between the ischial spines, an anterior-posterior diameter at the pelvic inlet and a transverse, inlet diameter of 11 and 12 cm, (3) an ultrasound at the time of presentation in labor indicating that the fetal head was not extended. After spontaneous onset of labor or indicated induction, continuous electronic fetal monitoring and epidural anesthesia were strongly encouraged. Cesarean section was performed for the usual maternal and fetal indications. Deliveries were by resident physicians with faculty supervision.
Maternal outcome variables included death, blood loss (both as a continuous variable as well dichotomized to p1500 or >1500 cm 3 ), need for blood transfusion, deep venous thrombosis, postoperative hematoma, wound infection requiring antibiotics, endomyometritis and febrile illness >1 day. In addition, a composite maternal morbidity variable (excluding those outcomes discussed above) was included. This variable includes the following outcomes: hypotension, ileus, urinary tract infection and wound dehiscence. Neonatal outcome variables included death, seizure, Apgar score <4 at 5 min, umbilical artery cord gas pH (both as a continuous variable as well as dichotomized to <7.00 and X7.00), umbilical artery cord gas base excess pÀ15, mechanically ventilation X1 day, admission to the intensive care nursery (ICN), brachial plexus injury, cephalohematoma, bone fracture and respiratory distress syndrome.
Statistics
Data were analyzed using two-sample t-tests or analysis of variance for normally distributed continuous data, Fisher's exact test or w 2 tests for categorical variables, and Mann-Whitney test for non-normally distributed continuous data. Differences in baseline characteristics were adjusted for using multivariable analysis. A P-value of p0.05 was considered statistically significant. Statistical analyses were performed with the use of STATA Version 7 software (STATA Corporation -College Station, TX, USA).
Ethics
Institutional Review Board approval was sought and obtained for both database analysis and chart review.
Results
During the study period, 795 women had persistent breech presentation ( Figure 1 ). Seventy subjects were excluded: 19 for major maternal disease, two for intrauterine fetal demise occurring before labor or planned cesarean section and 49 for major fetal anomaly. Of the remaining 725 women, 511 underwent planned elective cesarean section, 214 underwent a trial of vaginal delivery. Of the 214 women attempting a vaginal delivery 138 or 64.5% succeeded. See Figure 1 for the cesarean section indication for these women. Of note, medical record review revealed that the majority of women with the indication 'malpresentation' was believed to have frank or complete breech presentation and were allowed to labor until single or double footling presentation occurred. Baseline maternal characteristics are described in Table 1 . Of note, mean maternal age was older in the planned cesarean section group. There was no significant difference between the groups for parity, ethnicity or mean gestational age at delivery. Mean birth weights were higher in the cesarean section group. 
Discussion
Similar to our past studies, 4 ,7 the present retrospective study reveals increased neonatal morbidity with decreased maternal morbidity in women offered vaginal breech delivery compared to planned cesarean section. There were no perinatal, neonatal or maternal deaths associated with either planned vaginal or cesarean delivery. Despite an increased incidence in umbilical artery cord gas pH <7.00 and base excess pÀ15, no neonatal seizures were noted in the planned vaginal delivery group. There was an increased incidence in ventilator days X1 and ICN admission. The planned cesarean section group experienced an increased incidence in composite maternal morbidity, wound infection and endomyometritis. Despite an increased incidence in mean blood loss in the planned cesarean section group, there was no significant difference in blood loss >1500 cm 3 and need for blood transfusion.
The approach to the term breech at UCSF is designed to find healthy fetuses of average size or smaller in mothers who have adequate pelvic measurements and offer them a trial of labor. To support this approach, the success rate achieved was approximately 65%, with a substantially higher success rate (74%) when subjects with malpresentation were excluded from the planned vaginal delivery group. As stated above, there were a substantial number of patients who labored that were found to be footling as labor progressed. It is tempting to include these subjects in the elective cesarean section group as they ultimately proved to have exclusion criteria for a trial of labor. However, they were offered a trial of labor, and thus are included in that group for the final analysis. Of note, the success rate for achieving a vaginal delivery using somewhat similar protocols at other institutions has been even higher. 22, 23 The core of the breech debate becomes the consideration of 'hard' outcomes versus 'soft' and how to consider them together to make broad-based recommendations for breech delivery management. The most obvious 'hard' outcome is neonatal and maternal mortality. The number of neonatal deaths in the Term Breech Collaborative Trial is striking. We believe that these deaths can be prevented if select vaginal breech delivery is only offered at institutions that have the means to select appropriate patients and have adequate in-house anesthesia and obstetrical teams to deliver a fetus in distress within a reasonable period of time. Maternal mortality, although difficult to show with statistical power, is generally accepted, even without hard evidence, to be higher in women undergoing a major surgical procedure such as cesarean section. It is for this reason that we continue to offer vaginal delivery to women meeting our criteria. Thus, we consider a vaginal delivery to be optimal over cesarean delivery until proven otherwise.
In terms of the 'soft' outcomes, the debate continues. Decisions regarding mode of delivery are complicated given competing harms and benefits that affect both the mother and the fetus. In making shared, informed medical decisions with women, clinicians must determine if external evidence is applicable to her individual situation and provide evidence about benefits and harms. Sometimes the best evidence is derived from the individual experience of the labor and delivery unit. Clinicians need to elicit and integrate qualitative information concerning a woman's preferences and values. Many women will have strong preferences about mode of delivery; although many will desire cesarean section, others may opt for vaginal delivery. Although evidence from randomized trials most often provides the best available quantitative information, attention to clinical judgment and sensitivity to women's preferences are warranted to ensure that an individual's autonomy is respected. Our experience suggests that vaginal breech delivery is a safe option for women meeting the criteria that we have outlined and we feel this choice should continue to be offered to appropriately counseled, select women as part of good obstetrical care.
One of the greatest limitations of our study is the lack of longterm follow-up in both the neonates and mothers. Women who undergo cesarean section delivery generally have greater morbidity in both the peripartum period as well as with future deliveries and/ or surgeries. These outcomes are difficult to collect and quantify but deserve attention. Next, one worrisome finding in our analysis of neonatal outcomes included an increased risk of acidemia in the vaginal delivery group. Although this was not a precursor to seizure or death in the neonatal period, it does warrant speculation regarding long-term neurologic development. Other limitations of our study include possible confounding by unrecognized factors. We excluded major maternal disease as well as fetal anomalies as these issues prevent a patient from inclusion in our term breech protocol. These patients warrant an individualized approach to delivery based on the specific disease involved. Our inclusion and exclusion criteria did decrease the number of patients available for analysis; therefore, it is possible that we lacked power to see a significant difference in some of the major outcomes. Lastly, although we did a directed chart review to confirm information in the database, there is a potential data error (5-7%) and missing data points for some of the outcome variables.
We hope to demonstrate that this debate continues to warrant further research. Specifically, there is a need for the results of long-term maternal and neonatal outcomes in the women who have undergone cesarean section versus vaginal delivery for the term breech. Second, there is a need for a multicenter prospective cohort study or randomized controlled trial within the United States at institutions that can offer a protocol similar to ours in order to decipher whether using strict criteria can safely select appropriate patients for a trial of vaginal delivery to the term breech. 
